Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States
出版年份 2020 全文链接
标题
Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States
作者
关键词
-
出版物
CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-01-31
DOI
10.1002/cncr.32724
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States
- (2019) Ang Li et al. THROMBOSIS RESEARCH
- Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosis
- (2019) Nathan T. Connell et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta‐analysis
- (2019) Ang Li et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
- (2018) Ang Li et al. THROMBOSIS RESEARCH
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature
- (2017) Yvonne M. Ende-Verhaar et al. EUROPEAN RESPIRATORY JOURNAL
- Epidemiology of first and recurrent venous thromboembolism in patients with active cancer
- (2017) Anja Katholing et al. THROMBOSIS AND HAEMOSTASIS
- Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol
- (2016) Holger J Schünemann et al. BMJ Open
- Rituximab for the first-line treatment of stage III–IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
- (2014) D Papaioannou et al. HEALTH TECHNOLOGY ASSESSMENT
- Prophylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer
- (2014) Jean M. Connors NEW ENGLAND JOURNAL OF MEDICINE
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer
- (2014) Alexander T. Cohen et al. THROMBOSIS AND HAEMOSTASIS
- Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
- (2013) Susan R Kahn et al. LANCET
- Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Estimating Quality of Life in Acute Venous Thrombosis
- (2013) Kerstin Hogg et al. JAMA Internal Medicine
- Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2011) Dorothy Romanus et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Excess Costs Associated with Patients with Pulmonary Arterial Hypertension in a US Privately Insured Population
- (2011) Noam Y. Kirson et al. Applied Health Economics and Health Policy
- Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
- (2009) Giancarlo Agnelli et al. LANCET ONCOLOGY
- Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial
- (2009) Desmond Curran et al. QUALITY OF LIFE RESEARCH
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
- Cost‐effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome
- (2008) Janice S. Kwon et al. CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now